Online Pharmaceutical Schedule - August 2018
|Nucleosides Reverse Transcriptase Inhibitors|
Efavirenz with emtricitabine and tenofovir disoproxil fumarate - Special Authority SA1651 -- Retail pharmacy
Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg
Note: Efavirenz with emtricitabine and tenofovir disoproxil fumarate counts as three anti-retroviral medications for the purposes of the anti-retroviral Special Authority
|HIV Prophylaxis and Treatment|
Emtricitabine with tenofovir disoproxil fumarate - Subsidy by endorsement ; can be waived by Special Authority SA1714
Tab 200 mg with tenofovir disoproxil fumarate 300 mg
Endorsement for treatment of HIV: Prescription is deemed to be endorsed if emtricitabine with tenofovir disoproxil fumarate is co-prescribed with another antiretroviral subsidised under Special Authority SA1651 and the prescription is annotated accordingly by the Pharmacist or endorsed by the prescriber.
Emtricitabine with tenofovir disoproxil fumarate prescribed under endorsement for the treatment of HIV is included in the count of up to 4 subsidised antiretrovirals, and counts as two antiretroviral medications, for the purposes of Special Authority SA1651, page 1
There is an approval process to become a named specialist to prescribe antiretroviral therapy in New Zealand. Further information is available on the PHARMAC website.
For eye preparations refer to Eye Preparations, Anti-Infective Preparations, page 201